GET THE APP

Pharmacoproteomics News | Open Access Journals

Pharmacoeconomics: Open Access

ISSN: 2472-1042

Open Access

Submit Manuscript

Pharmacoproteomics News

Pharmacoproteomics is a quickly propelling field wherein the strategies of proteomics are applied to create pharmaceutical specialists. The word itself was begat just in 1997.

Be that as it may, this part of study assumes a significant job in customized medication. The word proteomics itself implies the investigation of proteomes, a proteome being the full supplement of proteins communicated by a living being or tissue under determined conditions at a predefined time.

Proteomes are accordingly powerful, and a given human may have a proteome with upwards of 2,000,000 proteins. The utilization of this full arrangement of proteins to examine the impact of infection or medications can fill in for considerably more intricate measures in pharmacodynamics at a lower cost in time, money related yield, and clinical hazard.

High Impact List of Articles

Evaluation of the Economic Impact for the Management of Patients Confirmed by COVID-19 Infection in Peru
Raul Montalvo Otivo*, Salome Ochoa, JF Quispe-Pari, Jorge De La Cruz, Julio Rosales and Angela Gomez
Research: Pharmacoeconomics: Open Access
Evaluation of the Economic Impact for the Management of Patients Confirmed by COVID-19 Infection in Peru
Raul Montalvo Otivo*, Salome Ochoa, JF Quispe-Pari, Jorge De La Cruz, Julio Rosales and Angela Gomez
Research: Pharmacoeconomics: Open Access
Market Analysis of Pharmaceuticals - Medicine-Pharma-2020
James Okeya
Market Analysis: Pharmacoeconomics: Open Access
Market Analysis of Pharmaceuticals - Medicine-Pharma-2020
James Okeya
Market Analysis: Pharmacoeconomics: Open Access
The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model
Riad Elmor, Walter Sandulli and Charles A. Carter
Research Article: Pharmacoeconomics: Open Access
The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model
Riad Elmor, Walter Sandulli and Charles A. Carter
Research Article: Pharmacoeconomics: Open Access
A Review of Pharmacoeconomics and a Discussion on Branded, Branded Generics and Generics
Sunitha Gangone, Divyasri Godala and Sriharsha Veena Kashetti
Review: Pharmacoeconomics: Open Access
A Review of Pharmacoeconomics and a Discussion on Branded, Branded Generics and Generics
Sunitha Gangone, Divyasri Godala and Sriharsha Veena Kashetti
Review: Pharmacoeconomics: Open Access
The Seven Myths of Health and Health Care
Peter Zweifel
Commentary: Pharmacoeconomics: Open Access
The Seven Myths of Health and Health Care
Peter Zweifel
Commentary: Pharmacoeconomics: Open Access

Conference Proceedings

Where the US biosimilars market is going and when it might get there
Stanton R Mehr
Keynote: Journal of Bioanalysis & Biomedicine
Where the US biosimilars market is going and when it might get there
Stanton R Mehr
Keynote: Journal of Bioanalysis & Biomedicine
Biosimilar globalization, a silver lining in untested waters! Biosimilars in China: Balance of risks and opportunities
Candida Fratazzi
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilar globalization, a silver lining in untested waters! Biosimilars in China: Balance of risks and opportunities
Candida Fratazzi
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Genotoxic/anti-genotoxic activities of Clematis flammula extracts
Atmani Dina, Tahiri Ouahiba, Debbache-Benaida Nadjet, Ayouni Karima, Berboucha Meriem, Saidene Naima, Charid Imene, Frederic Amant and Stefanie Schrauwen
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Genotoxic/anti-genotoxic activities of Clematis flammula extracts
Atmani Dina, Tahiri Ouahiba, Debbache-Benaida Nadjet, Ayouni Karima, Berboucha Meriem, Saidene Naima, Charid Imene, Frederic Amant and Stefanie Schrauwen
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Biowaivers: A delicate balance between biosimilars and innovations
Poongothai A R and Vijay Kumar M
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biowaivers: A delicate balance between biosimilars and innovations
Poongothai A R and Vijay Kumar M
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars in emerging markets: Regulatory and commercial considerations
Rodeina Challand
Keynote: Journal of Bioanalysis & Biomedicine
Biosimilars in emerging markets: Regulatory and commercial considerations
Rodeina Challand
Keynote: Journal of Bioanalysis & Biomedicine
Impact of pharma regulations on pharmaceutical economy
Prathyusha. A
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Impact of pharma regulations on pharmaceutical economy
Prathyusha. A
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 106

Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report

Pharmacoeconomics: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals